Pharmabiz7h
Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis
Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Overwhelming shareholder support in favour of take-private transaction with AditxtStudies presented at IDWeek 2024™ demonstrate ATI-1701 provides ...
TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...
USA Today22h
Treatment offers promise for 'terrible, terrible' brain cancer in young people
By the time she was treated, she was almost completely paralyzed, Monje said. The treatment worked so well that her tumor ...
Chicago Sun-Times6h
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
The drugs are another option for patients to manage their weight, and surgery remains the gold standard treatment for severe ...